Featured post

SCS research and awards news

For all our research and awards news, please visit our news page.

Sunday 24 January 2016

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Stephen Opat et al. published in the New England Journal of Medicine.

Read article here.

No comments:

Post a Comment